Rules affected: OAR 836-200-0600, 836-200-0605, 836-200-0610, 836-200-0615, 836-200-0620, 836-200-0625, 836-200-0630, 836-200-0635, 836-200-0640, 836-200-0645, 836-200-0650, 836-200-0655, 836-200-0660, 836-200-0670
Rule Summary:
These rules establish provisions for the permanent administration of the pharmaceutical representative licensing program created by Senate Bill 763 (2021).
Temporary rules were put in place in December of 2021 to facilitate administration of the licensing program during calendar year 2022. These temporary rules expired June 17, 2022.
These permanent rules effective June 17, 2022 replace the temporary rules.
Filed: June 16, 2022
Effective: June 17, 2022
Documents: